Identification of new breast cancer biomarkers in Black women

Dr Paola Marignani is studying HER2‑positive breast cancer in women of African ancestry to target care to this group, leading to earlier cancer diagnoses of and better, more personalized treatment. Black women have the highest mortality rates for breast cancer world‑wide, and research has shown that they have a higher likelihood of HER2‑positive breast cancer than any other type of breast cancer. Dr Paola Marignani and her team are tapping into advanced laboratory technologies and artificial intelligence to identify unique biomarkers for HER2‑positive breast cancer in women of African ancestry. These biomarkers could enable earlier diagnosis of HER2-positive breast cancer in women of African ancestry, which would improve survival.